Patents by Inventor Ashok V. Katdare

Ashok V. Katdare has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dry mix formulation for bisphosphonic acids
    Patent number: 6090410
    Abstract: Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by direct compression/dry mix tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.
    Type: Grant
    Filed: August 28, 1998
    Date of Patent: July 18, 2000
    Assignee: Merck & Co., Inc.
    Inventors: Simon R. Bechard, Kenneth A. Kramer, Ashok V. Katdare
  • Dry mix formulation for bisphosphonic acids
    Patent number: 5882656
    Abstract: Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by direct compression/dry mix tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.
    Type: Grant
    Filed: October 8, 1997
    Date of Patent: March 16, 1999
    Assignee: Merck & Co., Inc.
    Inventors: Simon R. Bechard, Kenneth A. Kramer, Ashok V. Katdare
  • Effervescent alendronate formulation
    Patent number: 5853759
    Abstract: An effervescent formulation of alendronate contains an acid source, a carbonate source, a binder, a lubricant and optionally, flavoring agents, colorants and sweeteners.
    Type: Grant
    Filed: May 8, 1997
    Date of Patent: December 29, 1998
    Assignee: Merck & Co.. Inc.
    Inventors: Ashok V. Katdare, Kenneth A. Kramer, Colin R. Gardner
  • Dry mix formulation for bisphosphonic acids
    Patent number: 5681590
    Abstract: Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by direct compression/dry mix tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.
    Type: Grant
    Filed: July 26, 1995
    Date of Patent: October 28, 1997
    Assignee: Merck & Co., Inc.
    Inventors: Simon R. Bechard, Kenneth A. Kramer, Ashok V. Katdare
  • Oral liquid alendronate formulations
    Patent number: 5462932
    Abstract: Disclosed is a therapy protocol for treating and for preventing bone loss in patients who have difficulty in swallowing by administering a liquid formulation of alendronate which can be easily swallowed. Also described are pharmaceutical dosage forms of a syrup, aqueous solution, a solution formed from a reconstituted powder, of alendronate, for carrying out the therapeutic method.
    Type: Grant
    Filed: May 17, 1994
    Date of Patent: October 31, 1995
    Assignee: Merck & Co., Inc.
    Inventors: Gerald S. Brenner, Ashok V. Katdare, Denise Pretzer, Donna T. Whiteford
  • Dry mix formulation for bisphosphonic acids with lactose
    Patent number: 5358941
    Abstract: Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by direct compression/dry mix tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.
    Type: Grant
    Filed: December 2, 1992
    Date of Patent: October 25, 1994
    Assignee: Merck & Co., Inc.
    Inventors: Simon R. Bechard, Kenneth A. Kramer, Ashok V. Katdare
  • Phthalazineacetic acid composition and tablet
    Patent number: 4910022
    Abstract: A tablet composition for a phthalazineacetic acid compound to be employed in treating clinical effects associated with diabetes is described. The composition permits formation of tablets having a relatively high dose of drug in a relatively small size useful for gaining patient compliance. The preferred phthalazineacetic acid compound is 3-((4-bromo-2-fluorophenyl)methyl)-3,4-dihydro-4-oxo-1-phthalazineacetic acid.
    Type: Grant
    Filed: November 15, 1988
    Date of Patent: March 20, 1990
    Assignee: Merck & Co., Inc.
    Inventors: Joseph F. Bavitz, Ashok V. Katdare
  • Method for tablet preparation
    Patent number: 4898736
    Abstract: Dose uniformity in formulations of highly potent drugs may be achieved by distributing a solution of the active ingredient over a directly compressible tableting vehicle with subsequent evaporation of the solvent, followed by tableting.
    Type: Grant
    Filed: March 9, 1988
    Date of Patent: February 6, 1990
    Assignee: Merck & Co., Inc.
    Inventor: Ashok V. Katdare
  • Tablet and formulation
    Patent number: 4639458
    Abstract: A direct compression tablet formulation containing a non-hydrated quinoline carboxylic acid type antibacterial agent.
    Type: Grant
    Filed: January 22, 1985
    Date of Patent: January 27, 1987
    Assignee: Merck & Co., Inc.
    Inventor: Ashok V. Katdare
  • Tablet
    Patent number: D375157
    Type: Grant
    Filed: December 22, 1992
    Date of Patent: October 29, 1996
    Assignee: Merck & Co., Inc.
    Inventors: Kenneth A. Kramer, Ashok V. Katdare
  • Pharmaceutical tablet
    Patent number: D379223
    Type: Grant
    Filed: September 13, 1995
    Date of Patent: May 13, 1997
    Assignee: Merck & Co., Inc.
    Inventors: Kenneth A. Kramer, Ashok V. Katdare
  • Pharmaceutical tablet
    Patent number: D400672
    Type: Grant
    Filed: March 21, 1996
    Date of Patent: November 3, 1998
    Assignee: Merck & Co., Inc.
    Inventors: Kenneth A. Kramer, Ashok V. Katdare
  • Tablet
    Patent number: D425614
    Type: Grant
    Filed: April 16, 1999
    Date of Patent: May 23, 2000
    Assignee: Merck & Co., Inc.
    Inventors: Tzyy-Show H. Chen, Thomas G. Nyairo, Ashok V. Katdare
  • Tablet
    Patent number: D430285
    Type: Grant
    Filed: April 16, 1999
    Date of Patent: August 29, 2000
    Assignee: Merck & Co., Inc.
    Inventors: Tzyy-Show H. Chen, Ashok V. Katdare, Thomas G. Nyairo
  • Tablet
    Patent number: D431076
    Type: Grant
    Filed: July 7, 1999
    Date of Patent: September 19, 2000
    Assignee: Merck & Co., Inc.
    Inventors: Tzyy-Show H. Chen, Thomas G. Nyairo, Ashok V. Katdare
  • Tablet
    Patent number: D434846
    Type: Grant
    Filed: July 7, 1999
    Date of Patent: December 5, 2000
    Assignee: Merck & Co., Inc.
    Inventors: Tzyy-Show H. Chen, Thomas G. Nyairo, Ashok V. Katdare